Cargando…
Durvalumab-associated Late-onset Myocarditis Successfully Treated with Corticosteroid Therapy
We herein report a 66-year-old man with locally advanced non-small-cell lung cancer (NSCLC) who developed durvalumab-associated myocarditis. The patient underwent durvalumab administration every two weeks following concurrent chemoradiotherapy, without any adverse events or apparent disease progress...
Autores principales: | Maetani, Tomoki, Hamaguchi, Toka, Nishimura, Takafumi, Marumo, Satoshi, Fukui, Motonari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907760/ https://www.ncbi.nlm.nih.gov/pubmed/34433717 http://dx.doi.org/10.2169/internalmedicine.7644-21 |
Ejemplares similares
-
Squamous Cell Carcinoma of the Lung Presenting Unilateral Thoracic Hyperhidrosis: A Case Report and Review of Literature
por: Hayashi, Yusuke, et al.
Publicado: (2022) -
An Uncommon Case of Myocarditis Secondary to Durvalumab Plus Tremelimumab
por: Diaz-Rodriguez, Porfirio E, et al.
Publicado: (2023) -
Mycobacterium triplex pulmonary disease in an immunocompetent host: A case report and literature review
por: Shirata, Masahiro, et al.
Publicado: (2019) -
Legionnaire’s disease presenting as bilateral central scotomata: a case report
por: Yamada, Sho, et al.
Publicado: (2021) -
Adult T Cell Leukemia/Lymphoma Becoming Apparent during Treatment of Pulmonary Abscess and Empyema Caused by Nocardia asiatica: A Case Report and Review of the Literature
por: Hayashi, Yusuke, et al.
Publicado: (2021)